Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > For newbies…synopsis
View:
Post by givmeabrake on Nov 06, 2015 12:33am

For newbies…synopsis

<div style="color: rgb(0, 0, 0); font-family: Helvetica; font-size: medium; orphans: 2; text-align: -webkit-auto; widows: 2; word-wrap: break-word; -webkit-nbsp-mode: space; -webkit-line-break: after-white-space;"> <div style="text-align: -webkit-auto; word-wrap: break-word; -webkit-nbsp-mode: space; -webkit-line-break: after-white-space;"> <div> <span style="color: rgb(34, 34, 34); font-family: Arial; text-align: -webkit-auto;">The company&nbsp;</span></div> <div> <font face="Arial"><span style="color: rgb(34, 34, 34);">Under the radar&nbsp;</span><br style="color: rgb(34, 34, 34);" /> <span style="color: rgb(34, 34, 34);">New mangement focussed and effective</span><br style="color: rgb(34, 34, 34);" /> <span style="color: rgb(34, 34, 34);">Enough cash no more dilution in-site</span><br style="color: rgb(34, 34, 34);" /> <span style="color: rgb(34, 34, 34);">Scalling up for production and sales&nbsp;</span><br style="color: rgb(34, 34, 34);" /> <span style="color: rgb(34, 34, 34);">Clearly confident in a Feb FDA go-ahead</span></font></div> <div> <font face="Arial">Undervalued STILL - &nbsp;see link<br style="color: rgb(34, 34, 34);" /> <br /> <br style="color: rgb(34, 34, 34);" /> <span style="color: rgb(34, 34, 34);">The Drug</span><br style="color: rgb(34, 34, 34);" /> <span style="color: rgb(34, 34, 34);">Endorsed by docs (Urologists)</span><br style="color: rgb(34, 34, 34);" /> <span style="color: rgb(34, 34, 34);">Safe - in fact it boosts immune response&nbsp;</span></font></div> <div> <font face="Arial">Effective results - exceed competition<br style="color: rgb(34, 34, 34);" /> <span style="color: rgb(34, 34, 34);">FDA has guided them through app process</span><br style="color: rgb(34, 34, 34);" /> <span style="color: rgb(34, 34, 34);">FDA set up Advisory Committee review (very positive)</span><br style="color: rgb(34, 34, 34);" /> <span style="color: rgb(34, 34, 34);">AdCom YES (oncology) Higher rate of approval 100% see link below</span></font></div> <div> <span style="color: rgb(34, 34, 34);"><font face="Arial">BCG the current #1 solution is not reliably available see link&nbsp;</font></span></div> <div> <span style="color: rgb(34, 34, 34);"><font face="Arial">Huge mfg margin&nbsp;</font></span></div> <div> <span style="color: rgb(34, 34, 34);"><font face="Arial">Production facility ready and waiting</font></span></div> <div> &nbsp;</div> <div> &nbsp;</div> <div> <span style="color: rgb(34, 34, 34);"><font face="Arial">The Future</font></span></div> <div> <font color="#222222" face="Arial">The drug is not limited to bladder THINK about that</font></div> <div> <font color="#222222" face="Arial">The drug could easily move to first line therapy</font></div> <div> &nbsp;</div> <div> &nbsp;</div> <div> <a href="https://seekingalpha.com/author/sujan-lahiri/instablog">https://seekingalpha.com/author/sujan-lahiri/instablog</a></div> <div> &nbsp;</div> <div> <a href="https://www.ashp.org/menu/DrugShortages/CurrentShortages/bulletin.aspx?id=915">https://www.ashp.org/menu/DrugShortages/CurrentShortages/bulletin.aspx?id=915</a></div> </div> <br class="Apple-interchange-newline" style="text-align: -webkit-auto;" /> <a href="https://lsconnect.thomsonreuters.com/fda-advisory-committee-votes/" style="text-align: -webkit-auto;">https://lsconnect.thomsonreuters.com/fda-advisory-committee-votes/</a></div> <br />
Comment by vega509 on Nov 06, 2015 6:42am
you might want to repost this, it is unreadable in its current format.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse